Loading…

LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION

Background and Aim:  In order to reduce gastric cancer death, mass screening for gastric cancer has been established in Japan for several decades. Only photofluorography is considered to be an acceptable screening method so far, but recent evidence may show the usefulness of serum pepsinogen (PG) me...

Full description

Saved in:
Bibliographic Details
Published in:Digestive endoscopy 2009-04, Vol.21 (2), p.78-81
Main Authors: Miki, Kazumasa, Fujishiro, Mitsuhiro, Kodashima, Shinya, Yahagi, Naohisa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3079-cb5c58824659c6a57fe8aca3a86a4b2c995098a0c80773b24d4271ca83603d993
container_end_page 81
container_issue 2
container_start_page 78
container_title Digestive endoscopy
container_volume 21
creator Miki, Kazumasa
Fujishiro, Mitsuhiro
Kodashima, Shinya
Yahagi, Naohisa
description Background and Aim:  In order to reduce gastric cancer death, mass screening for gastric cancer has been established in Japan for several decades. Only photofluorography is considered to be an acceptable screening method so far, but recent evidence may show the usefulness of serum pepsinogen (PG) measurement for gastric cancer screening. The aim of the present study was to elucidate the feasibility of measuring serum PG levels for detection of gastric cancers. Methods:  Serum PG levels (PGI/PGII) were measured in asymptomatic middle‐aged Japanese between 1991 and 2005. Those with a PGI ≤ 70 ng/mL and PGI/PGII ≤ 3 were defined as having a positive PG test. According to the obtained results of serum PG levels and previous individual records, those with a positive PG test and those with a negative PG test took gastroendoscopy every 2 and 5 years, respectively. Results:  The total number of participating individuals was 101 892 (mean age of 48.7 years). In a total of 21 178 planned gastroendoscopies (20.8%), 13 789 (65.1%) underwent gastroendoscopy and 125 gastric cancers were detected, which corresponded to 0.12% of all participants and to 0.91% of those with gastroendoscopy. Early‐stage cancers and intestinal‐type intramucosal cancers accounted for 80% and 39% of all the detected cancers, respectively. Conclusions:  Serum PG measurement for mass screening of gastric cancer enabled us to achieve high recruitment for gastroendoscopy in intended individuals, a favorable detection rate of gastric cancer and, in particular, an extremely high proportion of early‐stage gastric cancer in all the detected cancers.
doi_str_mv 10.1111/j.1443-1661.2009.00839.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67596390</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67596390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3079-cb5c58824659c6a57fe8aca3a86a4b2c995098a0c80773b24d4271ca83603d993</originalsourceid><addsrcrecordid>eNqNkc2O0zAUhS0EYjoDr4C8YpeMHSeOLbGxEk9alD_FzoKV5bqp1KqlQ0LFzI4nQDwjT4JDK9jixbXl-91zpXMAgBiF2J_7fYjjmASYUhxGCPEQIUZ4-PQCLP42XoIF4jgJEkqSG3A7TXuEcMTj-DW4wZxynKZsAX6UTV38-v5Ty66CnVR9qRVsHmAhlO5WGcxEnckOqqyTsl7VBezVXPVSQiW7voKtbP1PU8gaaqk0rKReNjkUldeFooZCfapa3VRCe7Vqleel9OtEIXP4UbSilkrCtmn70gNN_Qa82trDNLy93negf5A6WwZlU6wyUQaOoJQHbp24hLEopgl31CbpdmDWWWIZtfE6cpwniDOLHENpStZRvImjFDvLCEVkwzm5A-8vuo_j6ct5mL6a425yw-FgPw-n82RomnBKOPIgu4BuPE3TOGzN47g72vHZYGTmLMzezJab2XIzZ2H-ZGGe_Oi7647z-jhs_g1ezffAhwvwbXcYnv9b2OSy9g_yG7BpjhI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67596390</pqid></control><display><type>article</type><title>LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Miki, Kazumasa ; Fujishiro, Mitsuhiro ; Kodashima, Shinya ; Yahagi, Naohisa</creator><creatorcontrib>Miki, Kazumasa ; Fujishiro, Mitsuhiro ; Kodashima, Shinya ; Yahagi, Naohisa</creatorcontrib><description>Background and Aim:  In order to reduce gastric cancer death, mass screening for gastric cancer has been established in Japan for several decades. Only photofluorography is considered to be an acceptable screening method so far, but recent evidence may show the usefulness of serum pepsinogen (PG) measurement for gastric cancer screening. The aim of the present study was to elucidate the feasibility of measuring serum PG levels for detection of gastric cancers. Methods:  Serum PG levels (PGI/PGII) were measured in asymptomatic middle‐aged Japanese between 1991 and 2005. Those with a PGI ≤ 70 ng/mL and PGI/PGII ≤ 3 were defined as having a positive PG test. According to the obtained results of serum PG levels and previous individual records, those with a positive PG test and those with a negative PG test took gastroendoscopy every 2 and 5 years, respectively. Results:  The total number of participating individuals was 101 892 (mean age of 48.7 years). In a total of 21 178 planned gastroendoscopies (20.8%), 13 789 (65.1%) underwent gastroendoscopy and 125 gastric cancers were detected, which corresponded to 0.12% of all participants and to 0.91% of those with gastroendoscopy. Early‐stage cancers and intestinal‐type intramucosal cancers accounted for 80% and 39% of all the detected cancers, respectively. Conclusions:  Serum PG measurement for mass screening of gastric cancer enabled us to achieve high recruitment for gastroendoscopy in intended individuals, a favorable detection rate of gastric cancer and, in particular, an extremely high proportion of early‐stage gastric cancer in all the detected cancers.</description><identifier>ISSN: 0915-5635</identifier><identifier>EISSN: 1443-1661</identifier><identifier>DOI: 10.1111/j.1443-1661.2009.00839.x</identifier><identifier>PMID: 19691778</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Biomarkers, Tumor - blood ; endoscopy ; Feasibility Studies ; Female ; Gastrectomy ; gastric cancer ; Gastroscopy ; Humans ; Male ; Mass Screening ; Middle Aged ; Neoplasm Staging ; Pepsinogen A - blood ; serum pepsinogen ; Stomach Neoplasms - blood ; Stomach Neoplasms - diagnosis ; Stomach Neoplasms - surgery</subject><ispartof>Digestive endoscopy, 2009-04, Vol.21 (2), p.78-81</ispartof><rights>2009 The Authors. © 2009 Japan Gastroenterological Endoscopy Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3079-cb5c58824659c6a57fe8aca3a86a4b2c995098a0c80773b24d4271ca83603d993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19691778$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miki, Kazumasa</creatorcontrib><creatorcontrib>Fujishiro, Mitsuhiro</creatorcontrib><creatorcontrib>Kodashima, Shinya</creatorcontrib><creatorcontrib>Yahagi, Naohisa</creatorcontrib><title>LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION</title><title>Digestive endoscopy</title><addtitle>Dig Endosc</addtitle><description>Background and Aim:  In order to reduce gastric cancer death, mass screening for gastric cancer has been established in Japan for several decades. Only photofluorography is considered to be an acceptable screening method so far, but recent evidence may show the usefulness of serum pepsinogen (PG) measurement for gastric cancer screening. The aim of the present study was to elucidate the feasibility of measuring serum PG levels for detection of gastric cancers. Methods:  Serum PG levels (PGI/PGII) were measured in asymptomatic middle‐aged Japanese between 1991 and 2005. Those with a PGI ≤ 70 ng/mL and PGI/PGII ≤ 3 were defined as having a positive PG test. According to the obtained results of serum PG levels and previous individual records, those with a positive PG test and those with a negative PG test took gastroendoscopy every 2 and 5 years, respectively. Results:  The total number of participating individuals was 101 892 (mean age of 48.7 years). In a total of 21 178 planned gastroendoscopies (20.8%), 13 789 (65.1%) underwent gastroendoscopy and 125 gastric cancers were detected, which corresponded to 0.12% of all participants and to 0.91% of those with gastroendoscopy. Early‐stage cancers and intestinal‐type intramucosal cancers accounted for 80% and 39% of all the detected cancers, respectively. Conclusions:  Serum PG measurement for mass screening of gastric cancer enabled us to achieve high recruitment for gastroendoscopy in intended individuals, a favorable detection rate of gastric cancer and, in particular, an extremely high proportion of early‐stage gastric cancer in all the detected cancers.</description><subject>Biomarkers, Tumor - blood</subject><subject>endoscopy</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Gastrectomy</subject><subject>gastric cancer</subject><subject>Gastroscopy</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Pepsinogen A - blood</subject><subject>serum pepsinogen</subject><subject>Stomach Neoplasms - blood</subject><subject>Stomach Neoplasms - diagnosis</subject><subject>Stomach Neoplasms - surgery</subject><issn>0915-5635</issn><issn>1443-1661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkc2O0zAUhS0EYjoDr4C8YpeMHSeOLbGxEk9alD_FzoKV5bqp1KqlQ0LFzI4nQDwjT4JDK9jixbXl-91zpXMAgBiF2J_7fYjjmASYUhxGCPEQIUZ4-PQCLP42XoIF4jgJEkqSG3A7TXuEcMTj-DW4wZxynKZsAX6UTV38-v5Ty66CnVR9qRVsHmAhlO5WGcxEnckOqqyTsl7VBezVXPVSQiW7voKtbP1PU8gaaqk0rKReNjkUldeFooZCfapa3VRCe7Vqleel9OtEIXP4UbSilkrCtmn70gNN_Qa82trDNLy93negf5A6WwZlU6wyUQaOoJQHbp24hLEopgl31CbpdmDWWWIZtfE6cpwniDOLHENpStZRvImjFDvLCEVkwzm5A-8vuo_j6ct5mL6a425yw-FgPw-n82RomnBKOPIgu4BuPE3TOGzN47g72vHZYGTmLMzezJab2XIzZ2H-ZGGe_Oi7647z-jhs_g1ezffAhwvwbXcYnv9b2OSy9g_yG7BpjhI</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Miki, Kazumasa</creator><creator>Fujishiro, Mitsuhiro</creator><creator>Kodashima, Shinya</creator><creator>Yahagi, Naohisa</creator><general>Blackwell Publishing Asia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200904</creationdate><title>LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION</title><author>Miki, Kazumasa ; Fujishiro, Mitsuhiro ; Kodashima, Shinya ; Yahagi, Naohisa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3079-cb5c58824659c6a57fe8aca3a86a4b2c995098a0c80773b24d4271ca83603d993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biomarkers, Tumor - blood</topic><topic>endoscopy</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Gastrectomy</topic><topic>gastric cancer</topic><topic>Gastroscopy</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Pepsinogen A - blood</topic><topic>serum pepsinogen</topic><topic>Stomach Neoplasms - blood</topic><topic>Stomach Neoplasms - diagnosis</topic><topic>Stomach Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miki, Kazumasa</creatorcontrib><creatorcontrib>Fujishiro, Mitsuhiro</creatorcontrib><creatorcontrib>Kodashima, Shinya</creatorcontrib><creatorcontrib>Yahagi, Naohisa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive endoscopy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miki, Kazumasa</au><au>Fujishiro, Mitsuhiro</au><au>Kodashima, Shinya</au><au>Yahagi, Naohisa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION</atitle><jtitle>Digestive endoscopy</jtitle><addtitle>Dig Endosc</addtitle><date>2009-04</date><risdate>2009</risdate><volume>21</volume><issue>2</issue><spage>78</spage><epage>81</epage><pages>78-81</pages><issn>0915-5635</issn><eissn>1443-1661</eissn><abstract>Background and Aim:  In order to reduce gastric cancer death, mass screening for gastric cancer has been established in Japan for several decades. Only photofluorography is considered to be an acceptable screening method so far, but recent evidence may show the usefulness of serum pepsinogen (PG) measurement for gastric cancer screening. The aim of the present study was to elucidate the feasibility of measuring serum PG levels for detection of gastric cancers. Methods:  Serum PG levels (PGI/PGII) were measured in asymptomatic middle‐aged Japanese between 1991 and 2005. Those with a PGI ≤ 70 ng/mL and PGI/PGII ≤ 3 were defined as having a positive PG test. According to the obtained results of serum PG levels and previous individual records, those with a positive PG test and those with a negative PG test took gastroendoscopy every 2 and 5 years, respectively. Results:  The total number of participating individuals was 101 892 (mean age of 48.7 years). In a total of 21 178 planned gastroendoscopies (20.8%), 13 789 (65.1%) underwent gastroendoscopy and 125 gastric cancers were detected, which corresponded to 0.12% of all participants and to 0.91% of those with gastroendoscopy. Early‐stage cancers and intestinal‐type intramucosal cancers accounted for 80% and 39% of all the detected cancers, respectively. Conclusions:  Serum PG measurement for mass screening of gastric cancer enabled us to achieve high recruitment for gastroendoscopy in intended individuals, a favorable detection rate of gastric cancer and, in particular, an extremely high proportion of early‐stage gastric cancer in all the detected cancers.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19691778</pmid><doi>10.1111/j.1443-1661.2009.00839.x</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0915-5635
ispartof Digestive endoscopy, 2009-04, Vol.21 (2), p.78-81
issn 0915-5635
1443-1661
language eng
recordid cdi_proquest_miscellaneous_67596390
source Wiley-Blackwell Read & Publish Collection
subjects Biomarkers, Tumor - blood
endoscopy
Feasibility Studies
Female
Gastrectomy
gastric cancer
Gastroscopy
Humans
Male
Mass Screening
Middle Aged
Neoplasm Staging
Pepsinogen A - blood
serum pepsinogen
Stomach Neoplasms - blood
Stomach Neoplasms - diagnosis
Stomach Neoplasms - surgery
title LONG‐TERM RESULTS OF GASTRIC CANCER SCREENING USING THE SERUM PEPSINOGEN TEST METHOD AMONG AN ASYMPTOMATIC MIDDLE‐AGED JAPANESE POPULATION
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A06%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=LONG%E2%80%90TERM%20RESULTS%20OF%20GASTRIC%20CANCER%20SCREENING%20USING%20THE%20SERUM%20PEPSINOGEN%20TEST%20METHOD%20AMONG%20AN%20ASYMPTOMATIC%20MIDDLE%E2%80%90AGED%20JAPANESE%20POPULATION&rft.jtitle=Digestive%20endoscopy&rft.au=Miki,%20Kazumasa&rft.date=2009-04&rft.volume=21&rft.issue=2&rft.spage=78&rft.epage=81&rft.pages=78-81&rft.issn=0915-5635&rft.eissn=1443-1661&rft_id=info:doi/10.1111/j.1443-1661.2009.00839.x&rft_dat=%3Cproquest_cross%3E67596390%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3079-cb5c58824659c6a57fe8aca3a86a4b2c995098a0c80773b24d4271ca83603d993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67596390&rft_id=info:pmid/19691778&rfr_iscdi=true